Sign Up to like & get
recommendations!
1
Published in 2020 at "Kidney international"
DOI: 10.1016/j.kint.2020.04.051
Abstract: Canagliflozin reduced kidney disease progression in participants with type 2 diabetes in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program that explored potential mediators of the effects of canagliflozin on kidney outcomes. The percent mediating effect…
read more here.
Keywords:
effects canagliflozin;
effect;
canagliflozin kidney;
type diabetes ... See more keywords